Corient Capital Partners’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-15,449
Closed -$647K 771
2021
Q4
$647K Buy
+15,449
New +$647K 0.04% 319